NAPLEX Practice Exam 2026 – All-in-One Guide to Mastering the North American Pharmacist Licensure Examination!

Aspirin 81 mg/day is recommended in diabetes for secondary prevention of cardiovascular events, particularly in patients with coronary artery disease (CAD) or peripheral artery disease (PAD). Both CAD and PAD are common conditions in diabetic patients and are associated with an increased risk of cardiovascular events. Aspirin helps to prevent blood clots from forming, reducing the risk of heart attacks and strokes in these patients. Therefore, the correct choice is A, CAD/PAD.

Hypertension, deep vein thrombosis (DVT), and heart failure are conditions that may require different treatment approaches, and Aspirin 81 mg/day is not specifically recommended for secondary prevention in these conditions.